CD4 and COVID-19: From the present study, there were significant differences in lymphocytes, NLR, CRP, AST, Cr, CD3+ T cells, CD4+ T cells, CD8+ T cells, CD19+ T cells, and CD16+/CD56+ NK cells in mild/moderate COVID-19 cases with and without progression.